SEC Form 4 · accession 0001179110-17-007697
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
May 18, 2017
Accepted (ET)
May 22, 2017 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | May 18, 2017 | M | 1,889 | $84.44 | A | 7,919 | D | |
| Ordinary Shares, par value $0.0001F1 | May 18, 2017 | S | 1,889 | $220.45 | D | 6,030 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Options (Right to Buy)F2 | $84.44 | May 18, 2017 | M | 1,889 | D | — | Aug 13, 2017 | Ordinary Shares | 1,889 | 0 | D |
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F2This option became vested and exercisable in four equal installments commencing on August 13, 2007.